ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Connecticut » Nurse Practitioner, Gerontology

Top Nurse Practitioner, Gerontology Prescribers in Connecticut

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
VIRGINIA HANNON A.P.R.N.

Nurse Practitioner, Gerontology

11,253

$839K

799
771 are 65+

6%
patients receiving schedule two controlled substances

Avg: 34%

3%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 20%

$75
Average prescription price

Avg: $61

DAVID STEVENSON APRN

Nurse Practitioner, Gerontology

4,057

$208K

155
126 are 65+

17%
patients receiving schedule two controlled substances

Avg: 34%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 20%

$51
Average prescription price

Avg: $61

SYLVIA PARKER GNP-BC

Nurse Practitioner, Gerontology

2,932

$114K

230
221 are 65+

16%
patients receiving schedule two controlled substances

Avg: 34%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 20%

$39
Average prescription price

Avg: $61

JOAN GEREG APRN

Nurse Practitioner, Gerontology

2,563

$174K

465
433 are 65+

3%
patients receiving schedule two controlled substances

Avg: 34%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 20%

$68
Average prescription price

Avg: $61

SHEILA MURPHY APRN

Nurse Practitioner, Gerontology

2,307

$136K

203
203 are 65+

14%
patients receiving schedule two controlled substances

Avg: 34%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 20%

$59
Average prescription price

Avg: $61

LEEANNE SHAW-QUINN APRN

Nurse Practitioner, Gerontology

1,788

$75.5K

185
185 are 65+

0%
patients receiving schedule two controlled substances

Avg: 34%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 20%

$42
Average prescription price

Avg: $61

MARY ELLEN PAGNOZZI A.P.R.N.

Nurse Practitioner, Gerontology

598

$32.1K

131
120 are 65+

53%
patients receiving schedule two controlled substances

Avg: 34%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 20%

$54
Average prescription price

Avg: $61

L. JONES A.P.R.N.

Nurse Practitioner, Gerontology

497

$28.2K

127
117 are 65+

32%
patients receiving schedule two controlled substances

Avg: 34%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 20%

$57
Average prescription price

Avg: $61

JOANNE BRICE APRN, NP-C

Nurse Practitioner, Gerontology

485

$20.5K

88
66 are 65+

55%
patients receiving schedule two controlled substances

Avg: 34%

23%
patients receiving schedule three controlled substances

Avg: 2%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 20%

$42
Average prescription price

Avg: $61

BARBARA BRIGANDI APRN

Nurse Practitioner, Gerontology

449

$26.2K

80
77 are 65+

55%
patients receiving schedule two controlled substances

Avg: 34%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 20%

$58
Average prescription price

Avg: $61

CHERYL WALKER APRN

Nurse Practitioner, Gerontology

407

$22.9K

116
90 are 65+

66%
patients receiving schedule two controlled substances

Avg: 34%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 20%

$56
Average prescription price

Avg: $61

MARIA HUTCHINSON APRN

Nurse Practitioner, Gerontology

340

$18.2K

80
72 are 65+

74%
patients receiving schedule two controlled substances

Avg: 34%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 20%

$53
Average prescription price

Avg: $61

EVELYN GODWIN A.P.R.N.

Nurse Practitioner, Gerontology

229

$6,957

42
40 are 65+

50%
patients receiving schedule two controlled substances

Avg: 34%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

0%
prescriptions for brand name drugs

Avg: 20%

$30
Average prescription price

Avg: $61

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank